Detailed Information

Cited 9 time in webofscience Cited 9 time in scopus
Metadata Downloads

Bupivacaine-induced contraction is attenuated by endothelial nitric oxide release modulated by activation of both stimulatory and inhibitory phosphorylation (Ser1177 and Thr495) of endothelial nitric oxide synthase

Authors
Lee, Soo HeePark, Chang-ShinOk, Seong-HoKim, DanaKim, Kyung NamHong, Jeong-MinKim, Ji-YoonIl Bae, SungAn, SeungminSohn, Ju-Tae
Issue Date
15-Jun-2019
Publisher
Elsevier BV
Keywords
Bupivacaine; Endothelial nitric oxide; Endothelial nitric oxide synthase; Src kinase; Caveolin-1; Vasoconstriction
Citation
European Journal of Pharmacology, v.853, pp 121 - 128
Pages
8
Indexed
SCI
SCIE
SCOPUS
Journal Title
European Journal of Pharmacology
Volume
853
Start Page
121
End Page
128
URI
https://scholarworks.gnu.ac.kr/handle/sw.gnu/9047
DOI
10.1016/j.ejphar.2019.03.026
ISSN
0014-2999
1879-0712
Abstract
This study examined the mechanism associated with the endothelium-dependent attenuation of vasoconstriction induced by bupivacaine (BPV), with a particular focus on the upstream cellular signaling pathway of endothelial nitric oxide synthase (eNOS) phosphorylation induced by BPV in human umbilical vein endothelial cells (HUVECs). BPV concentration-response curves were investigated in the isolated rat aorta. The effects of N omega-nitro-L-arginine methyl ester (L-NAME), 1H-[1,2,4]oxadiazolo[4,3-alpha]quinoxalin-1-one (ODQ), methylene blue, calmidazolium, the Src kinase inhibitor 4-amino-3-(4 chlorophenyl)-1-(t butyl)-1H-pyrazolo[3,4-d]pyrimidine, 4-amino-5-(4-chlorophenyl)-7-(t-butyl)pyrazolo[3,4-d]pyrimidine (PP2) and the combination of L-arginine and L-NAME on BPV-induced contraction in endothelium-intact aorta preparations were examined. The effects of BPV alone and in combination with PP2 on the phosphorylation of eNOS (at Ser1177 or Thr495), caveolin-1 and Src kinase were examined in HUVECs. BPV-induced contraction was lower in endothelium-intact aortae than in endothelium-denuded aortae. L-NAME, ODQ, methylene blue and calmidazolium increased BPV-induced contraction in endothelium-intact aortae, whereas PP2 alone and combined treatment with c-arginine and L-NAME inhibited BPV-induced contraction. Low-concentration BPV (30 mu M) induced both stimulatory (Ser1177) and inhibitory (Thr495) phosphorylation of eNOS in HUVECs. However, high-concentration BPV (150 mu M) induced only stimulatory (Ser1177) eNOS phosphorylation. Additionally, phosphorylation of Src kinase, caveolin-1 and inhibitory eNOS (Thr495) induced by low-concentration BPV was inhibited by PP2. These results suggest that contraction induced by low-concentration BPV is attenuated by endothelial nitric oxide release, which is modulated both stimulatory (Ser1177) and inhibitory eNOS phosphorylation (Thr495). BPV-induced phosphorylation of eNOS (Thr495) is indirectly mediated by an upstream cellular signaling pathway involving Src kinase (Tyr416) and caveolin-1 (Tyr14).
Files in This Item
There are no files associated with this item.
Appears in
Collections
College of Medicine > Department of Medicine > Journal Articles

qrcode

Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.

Related Researcher

Researcher Ok, Seong Ho photo

Ok, Seong Ho
의과대학 (의학과)
Read more

Altmetrics

Total Views & Downloads

BROWSE